In late April 2022, Eli Lilly released preliminary results from the SURMOUNT-1 trial that included overweight and obese patients using tirzepatide who did not have diabetes
Sitagliptin Add-on Therapy in Patients with Type 2 Diabetes Inadequately Controlled on Metformin Immediate-Release Alone In a 24-week placebo-controlled trial of sitagliptin 100 mg administered once daily added to a twice daily metformin immediate-release regimen, there were no adverse reactions reported regardless of investigator assessment of causality in 5% of patients and more commonly than in patients given placebo
however, it can be a perfectly reasonable alternative in the interim
Your vial will typically include: A colored cap over a rubber stopper A label showing the drug name, concentration, and active ingredient A beyond-use date and storage instructions The pharmacys contact information Youll use the same vial for multiple doses, drawing up your prescribed amount with a new syringe each week
Your licensed 503A compounding pharmacy provides consistent quality across every dose, and HSA/FSA eligibility means you can use tax-advantaged savings to cover your monthly cost
Can Obesema 1.7 mg Injection be self-administered at home
